Safex Chemicals India Limited IPO

The company derives a significant portion of the company's revenues from external customers for its branded formulation business (62.47%, 58.76% and 65.73% of the company's revenue from operations in Fiscals 2025, 2024 and 2023, respectively) and consequently any decline in the demand for such products may adversely affect its business, results of operations, financial condition and cash flows.

The company's business is subject to climatic conditions and is cyclical in nature. Seasonal variations and unfavourable local and global weather patterns may have an adverse effect on the company's business, results of operations, financial condition and cash flows.

The company has incurred losses during the last three Fiscals. The company had a loss for the year of Rs. 142.86 million, Rs. 227.88 million and Rs. 10.17 million in Fiscals 2025, 2024 and 2023, respectively. The company cannot assure you that the company will be able to generate profits and not incur losses in the future.

The company has not entered into any long-term contracts with our suppliers from whom the company procures raw materials required for the company's manufacturing operations and any delay, interruption or reduction in the supply of raw materials or volatility in the prices of raw materials, may adversely affect its business, results of operations, financial condition and cash flows.

The company derives a portion of the company's revenue from sale of products outside India (29.23%, 36.30% and 29.53% of its revenue from sale of products in Fiscals 2025, 2024 and 2023, respectively). Consequently, any adverse developments in such countries could have an adverse impact on the company's business, results of operations, financial condition and cash flows.

The company's manufacturing facilities are subject to operating risks and any slowdown or interruption to the company's manufacturing operations may have an adverse impact on its business, results of operations, financial condition and cash flows.

The company does not have long-term arrangements with its dealers in the company's branded formulation business, and the company's inability to expand or effectively manage its dealer network may have an adverse effect on the company's business, results of operations, financial condition and cash flows.

Failures to obtain or renew approvals, licenses, registrations and permits required to operate its business in a timely manner, or at all, may adversely affect the company's business and results of operations.

The company has in the past entered into related party transactions and may continue to do so in the future, which may potentially involve conflicts of interest with the equity shareholders.

The company is subjects to stringent technical specifications and quality requirements in relation to the company's products and any failure to comply with such standards may adversely affect its business and reputation.